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Goal
To combine research aims and the current NASA Space Cancer Risk (NSCR) 2012 model 
into an illustrative allegory.
Background
As one of the many risks inherent to space travel, radiation exposure over an astronaut’s career is limited by the space
permissible exposure limit (SPEL). This limit is defined in the NASA Standard 3001 [1] which states: Planned career exposure to
ionizing radiation shall not exceed three percent Risk of Exposure-Induced Death (REID) for cancer mortality at a 95 percent
confidence level. The REID quantifies the lifetime risk of death from radiation-induced cancer in an exposed astronaut. The
NASA Space Cancer Risk (NSCR) 2012 model [2] incorporates elements from physics, biology, epidemiology, and statistics to
generate the REID distribution. The current model quantifies the space radiation environment, radiation quality, and dose-rate
effects to estimate a NASA weighted dose. This weighted dose is mapped to the excess risk of radiation-induced cancer
mortality from acute exposures to gamma rays and then transferred to an astronaut population. Finally, the REID is determined
by integrating this risk over the individual’s expected lifetime. The calculated upper bound of the 95% confidence interval of the
REID is used to restrict an astronaut’s permissible mission duration (PMD) for a proposed mission. As a statistical quantity
characterized by broad, subjective uncertainties, probabilistic assessments of REID for space missions result in wide
distributions. Currently, the upper 95% confidence level is over 350% larger than the mean REID value, which can severely limit
an astronaut’s PMD.
The model incorporates inputs from multiple scientific disciplines in the risk estimation process. Physics and particle transport
models calculate how radiation moves through space, penetrates spacecraft, and makes its way to the human beings onboard.
Epidemiological studies of exposures from atomic bombs, medical treatments, nuclear materials, etc. are used to quantify
health risks from acute and chronic low linear energy transfer (LET) ionizing radiation. Biological studies in cellular and animal
models using radiation at various LETs and energies inform quality metrics for ions present in space radiation. Statistical
methodologies unite these elements, controlling for mathematical and scientific uncertainty and variability. Despite current
progress, these research platforms contain knowledge gaps contributing to the large uncertainties still present in the model. The
NASA Space Radiation Program Element (SRPE) defines the knowledge gaps that impact our understanding of cancer risks.
These gaps are outlined in NASA’s Human Research Roadmap [3], which identifies the research questions and actions
recommended for reducing the uncertainty in the current NSCR model and for formulation of future models.
The greatest contributors to uncertainty in the current model include radiation quality, low dose and dose-rate effects, and the
transfer of exposure-based risk from other populations to an astronaut population. Here, we discuss the current capabilities of
the NSCR-2012 model and several immediate research needs, highlighting areas expected to have an operational impact on
the current model schema.
Map Key
As demonstrated in the subway style map to the right, the NASA Quality Factor Function is the current mechanism that relates the
biological effects of sparsely ionizing (low LET) to densely ionizing (high LET) radiation. The current function parameterizes a risk cross
section that approximates the track-structure models originating from Katz [4]. This function only incorporates track structure differences
between ions with no integration of biological mechanisms. Ideally, human epidemiology data would provide a method to assimilate the
biological mechanisms which modify the physical attributes of the energy deposition spectrum. However, only sparse data exists regarding
the effects of high LET radiation on humans. It is therefore necessary to incorporate research findings from animal and cellular experiments
into models of radiation quality. Gap 3 highlights the research required to better understand the differences between the varying qualities of
radiation in space.
Subway-style notional map featuring the NSCR-2012 model
DDREF
NASA Quality Factor Function
The current NSCR 2012 model relies heavily on epidemiology data
for risk estimation. With the current model formulation the most
impactful areas of research include those that inform the radiation
quality factor and DDREF. As shown by the monorail of radiation
research, incorporation of new research findings in these areas into
the space radiation cancer risk model is a high priority of the SRPE
and is required for successful construction of the research connector
services (dashed purple lines) depicted on the subway map.
The NSCR-2012 model – Incorporates elements from physics, biology, 
epidemiology, and statistics to generate the REID.
Physics transport models – Calculate how radiation moves through 
space, penetrates spacecraft, and makes its way to the human beings 
onboard.
Absorbed Dose – “The expectation value of the energy imparted to matter 
per unit mass at a point.”[5]
NASA Quality Factor Function – A function that relates the biological 
effects of sparsely to densely ionizing radiation.
DDREF – A scaling factor that relates the biological effects of high dose 
acute radiation exposures to low dose chronic exposures.
NASA weighted Dose – A dose quantity calculated for individual 
organs/tissues derived from the absorbed dose and modified to reflect 
differences in radiation quality using the NASA Quality Factor Function.
Epidemiological studies – Exposures from the atomic bombings, medical 
treatments, nuclear material workers, etc. are used to quantify health 
risks from acute and chronic low LET ionizing radiation.
Acute γ-Ray Excess Risk Models – Excess Relative Risk (ERR) and 
Excess Absolute Risk (EAR) parameters estimated using epidemiological 
studies.
Transfer to Astronaut Population – The excess risk from epidemiological 
studies is transferred additively or multiplicatively to a population more 
representative of NASA Astronauts.
Excess Risk of Mortality – The risk of cancer mortality above the baseline 
risk at each age.
Lifetime Risk of Exposure Induced Death (REID) – The excess risk of 
mortality integrated over the individual’s expected lifetime.
Monorail of Radiation Research – Ground-based, peer-reviewed research using state 
of the art cell and animal models along with acquisition of ‘omics’ datasets will be 
conducted to reduce uncertainty in the current cancer risk model and more accurately 
quantify radiation cancer risk. Serves as the basis to bridge gaps included in the 
research connector service to the NSCR-2012 model.
Research connector service – Models and/or mechanisms to connect the biological 
research to the radiation risk model.  Currently under construction.
Physics express train – Research using state of the art detectors and models to 
describe the physical attributes of the ionizing radiation environment and its 
interaction with matter.
The Dose and Dose Rate Effectiveness Factor (DDREF) scales high doses and acute dose rates to low doses and chronic dose rates. The DDREF
should be characterized by a wide uncertainty distribution to reflect the ongoing debate in the radiation community of a good estimate for this scaling
factor. The uncertainty is complicated by the correlation between the dose rate and radiation quality effects. Gap 4 corresponds to research questions
focused on low dose, fractionated, and chronic exposures. It is important that current research includes exposures that are relevant to those experienced
in space, both in dose level as well as dose rate. Fractionated exposures may not be an appropriate surrogate for the biological response to true low
dose-rate protracted exposures. Furthermore, while measurements at low doses and dose rates are important, high dose exposures must be recorded as
well to enable the calculation of the DDREF metric. The SPRE’s Gaseous Core Reactor (GCR) simulator experimental consortium is currently focused on
developing the infrastructure required to successfully address these issues.
Conclusions
Gap 1 – Establish mechanisms of space radiation induced cancer initiation, 
promotion and progression for the highest risk tissues (lung, colon, stomach, 
breast, liver, and blood forming organs).
Gap 2 – Ascertain the mechanisms of space radiation induced cancer 
initiation, promotion and progression for the minor tissue sites (bladder, 
ovary, brain, esophagus, skin, etc.).
Gap 3 – Define the impact of radiation quality on cancer development 
processes and determine whether or not heavy ion effects can be scaled to 
gamma rays.
Gap 4 – Estimate low dose and dose rate effects for protons, heavy ions and 
secondary neutrons.
Gap 5 – Understand how genetic and epigenetic factors influence radiation 
sensitivity.
Gap 6 – Assess the impact of age and sex specific dependence on space 
radiation carcinogenesis.
Gap 7 – Integrate large ‘omics’ datasets into next generation cancer risk 
models using system biology approaches to improve predictions and 
evaluate countermeasures.
Gap 8 – Evaluate the most effective biomedical or dietary countermeasures 
to mitigate cancer risks due to space radiation exposure.
Gap 9 – Recognize whether other spaceflight factors (e.g. altered gravity, 
stress, altered immune function, altered circadian rhythms, depressed 
nutritional status) modify the carcinogenic risk from space radiation.
• Gap 10—Validation experiments (not represented in diagram).
Gap 11 – Calculate the most effective shielding approaches to mitigate 
cancer risks.
Gap 12 – Describe the primary space radiation environment and transport 
through spacecraft materials and tissue, evaluating dose composition in 
critical organs for mission relevant radiation environments.
Gap 13 – Develop an integrated radiation design and analysis tool compliant 
with NASA Standards and accessible to the engineering community.
Gap 14 – Identify biodosimetry methods and biomarkers to determine 
individual radiation susceptibility for early detection of adverse radiation 
induced health outcomes.
Gap 15 – Determine possible interactions between radiation and tobacco 
products.
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